Indications for Percutaneous Coronary Intervention and Stent Types
Drug-eluting stents (DES) should be your default choice for PCI to reduce restenosis risk, but only if the patient can tolerate and comply with 12 months of dual antiplatelet therapy (DAPT); otherwise, use bare-metal stents (BMS) or balloon angioplasty. 1
Indications for PCI
The primary indication for PCI is angina relief that translates into improved physical function and quality of life 2. PCI is performed across several clinical scenarios:
Acute Coronary Syndromes
- STEMI (ST-elevation myocardial infarction): Primary PCI is the standard treatment
- NSTEMI/Unstable Angina: PCI with appropriate stent selection based on bleeding risk and DAPT tolerance
Stable Coronary Disease
- Symptomatic angina despite optimal medical therapy
- Objective evidence of myocardial ischemia (though angiographically significant stenosis may justify PCI even without formal ischemia testing in severe lesions) 3
Special Circumstances
- Chronic total occlusions (CTOs) for angina relief 2
- Cardiogenic shock post-MI
- Before noncardiac surgery (timing considerations critical) 4
Critical caveat: PCI should NOT be performed if the patient cannot tolerate or comply with DAPT - this is a Class III (Harm) recommendation 1.
Types of Stents: Detailed Breakdown
Bare-Metal Stents (BMS)
Composition: Stainless steel or cobalt chromium alloys 1
DAPT Duration: Minimum 30 days (risk of stent thrombosis greatest in first 30 days) 1
Use BMS when:
- High bleeding risk exists
- Patient cannot comply with 12 months of DAPT
- Anticipated invasive or surgical procedures within 12 months that may require interrupting DAPT 1
Limitations: Higher restenosis rates compared to DES, requiring more repeat revascularizations 5
Drug-Eluting Stents (DES)
Four FDA-approved types in the United States 1:
1. Sirolimus-Eluting Stents
- Demonstrated reduced need for repeat revascularization vs BMS
- No increase in death or MI at 4-year follow-up
- Requires 12 months DAPT 1
2. Paclitaxel-Eluting Stents
- Reduced repeat revascularization vs BMS
- No increase in death or MI at 4-year follow-up
- Requires 12 months DAPT 1
3. Zotarolimus-Eluting Stents
- Similar outcomes to sirolimus and paclitaxel stents
- Reduced repeat revascularization vs BMS
- Requires 12 months DAPT 1
4. Everolimus-Eluting Stents
- Lower need for repeat revascularization than paclitaxel-eluting stents
- By inference, lower risk than BMS
- No increase in death or MI at 2-year follow-up
- Requires 12 months DAPT 1
Key DES Characteristics
Common features across all DES 1:
- Vary by scaffold material, design, drug content, and polymer for drug elution
- Associated with delayed healing based on pathologic studies
- Longer thrombosis risk period compared to BMS
- More expensive than BMS (though cost-effective due to fewer repeat procedures)
- Some practitioners extend DAPT beyond 12 months based on observational data, though RCTs haven't confirmed benefit
FDA approval trials: Originally recommended 3-6 months DAPT, but current consensus is 12 months to avoid late thrombosis 1
Specialized Stent Types
Covered Stents
- Utilized for over 2 decades in PCI 6
- Essential for managing complications
- Design has evolved: improved deliverability, less bulky
- Used for various coronary indications with mixed results 6
DAPT Algorithm by Clinical Scenario
For Elective PCI 1, 7:
- BMS: Aspirin + clopidogrel for minimum 4 weeks, then aspirin indefinitely
- DES: Aspirin + clopidogrel for 12 months, then aspirin indefinitely
For ACS (NSTEMI or STEMI) 7:
- Both BMS and DES: Dual antiplatelet therapy for minimum 12 months regardless of stent type
Critical Decision Point: Pre-Implantation Discussion
Before implanting DES, you must discuss with the patient 1:
- The need for DAPT
- Duration of DAPT (12 months minimum)
- Patient's ability to comply with DAPT
- Patient's ability to tolerate DAPT (bleeding risk assessment)
Perioperative Management Pitfall
If noncardiac surgery becomes necessary after PCI, most patients can undergo surgery on DAPT when risk-benefit favors continued therapy. If P2Y12 inhibitor must be held, continue aspirin if bleeding risk permits. No validated "bridging" strategy exists (e.g., GP IIb/IIIa inhibitors, antithrombin therapy) 1. Resume P2Y12 inhibitor as soon as possible postoperatively.
Additional PCI Techniques
Beyond stent selection, other techniques include 5:
- Thrombus aspiration
- Direct stenting
- Rotational atherectomy (Rotablation)
- Cutting balloon angioplasty
Recent data shows DES and mechanical thrombectomy demonstrate superior angiographic success rates and improved clinical outcomes, particularly in complex lesion subsets 5.